AI Insurtech Indigo Doubles Premium Volume to $20M Following Series B Success

Indigo, an AI-driven medical professional liability platform, has surpassed $20 million in premiums, doubling its volume since its $50 million Series B financing in January. This milestone signals a significant shift in the medical malpractice insurance sector, where technology-led underwriting is beginning to outperform traditional models amid rising claim severity and market-wide pricing pressures.

What was announced

Indigo has reached a premium volume milestone of more than $20 million, a figure that represents a 100% increase since the start of the year. This growth is attributed to several factors, including deeper penetration into larger physician groups and the continued expansion of the company’s curated broker network. The platform’s performance comes at a time when the broader medical malpractice insurance market is facing significant headwinds, characterized by "nuclear verdicts" and an increase in the severity of claims.

The company’s technology-led approach allows for a more granular assessment of risk. Unlike traditional carriers that often rely on group-level pricing, Indigo’s model evaluates risk at the individual physician level. This methodology ensures that lower-risk healthcare providers are priced based on their specific profiles, rather than being forced to subsidize higher-risk individuals within the same practice. This precision in risk assessment has led to a strong conversion rate among healthcare providers who are currently facing declining reimbursements and rising malpractice costs.

Efficiency is a core component of the announcement. Indigo is currently on pace to process over 10,000 submissions this year with a team of only five underwriters. Approximately 40% of all submissions now receive an automated decision, more than double the automation rate recorded last year. Furthermore, the median turnaround time for a quote is now under one business day. Underscoring this momentum, the company has been named to the 2026 Insurtech 50, CB Insights’ list of the world’s most promising insurtechs. The company’s next phase of growth will focus on continuing to scale its technology and expanding its product offering.

"Our credibility in the market is compounding as Indigo grows and this milestone is an encouraging proof point for our strategy and underwriting model. Indigo is extremely deliberate in its approach. Automating underwriting in medical malpractice requires deep expertise and an understanding of the nuances that contribute to individual physician or practice risk. With claim severity trending upward, precision in how we assess risk is more important than ever, and it’s clearly an approach that’s resonating with healthcare providers."

Jared Kaplan, CEO of Indigo.

The companies involved

Indigo is a vertically integrated insurance platform that specializes in medical professional liability. The company utilizes artificial intelligence to refine its underwriting processes, aiming to provide more accurate pricing for healthcare providers. By operating as a tech-driven entity in a traditionally manual sector, Indigo positions itself as a modern alternative to incumbent carriers. The company maintains its digital presence at getindigo.com and focuses on the medical malpractice niche, a segment of the insurance industry that has historically been slow to adopt automated risk assessment tools.

The firm’s recent trajectory was accelerated by a $50 million Series B financing round announced in January. This capital injection has supported the company’s efforts to scale its technology and expand its reach within the physician group market. Led by CEO Jared Kaplan, the company operates with a lean underwriting team, leveraging its proprietary AI to handle high submission volumes. Indigo’s model is designed to address the specific nuances of medical risk, moving away from the broad-brush actuarial methods that have defined the medical professional liability space for decades. Its recognition in the Insurtech 50 underscores its status as a growing player in the global insurance technology landscape.

What this means

The medical malpractice insurance sector is currently at a crossroads. Incumbent carriers are struggling to manage adverse development after years of pricing pressure, while the rise of AI tools in medicine adds a new layer of complexity to risk management. Indigo’s ability to double its premium volume in less than a year suggests that the market is losing patience with the cumbersome underwriting processes of legacy insurers. The industry is under immense pressure from "nuclear verdicts"—exceptionally high jury awards—which are driving up costs across the board. For the wider insurtech sector, this demonstrates that AI's most valuable application is in the precision-pricing of high-stakes, complex risks that traditional models can no longer accurately quantify.